Product
C19-IG
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of Anti-COVID-19 Immune Globulin (Human) 20% (C19-IG 20%) Versus Placebo in Asymptomatic Ambulatory Outpatients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionStatus: Terminated, Estimated PCD: 2021-11-10